• 

  On the Brink of a Lecanemab FDA Decision, What Do We Know About the Drug’s Safety?
• 

  Beyond the Hype: What Does the Lecanemab News Mean for People with Alzheimer’s?
• 

  Cuba Has an Experimental Alzheimer’s Drug In Human Trials
• 

  A New Kind of Alzheimer’s Drug, AD101, Makes Its Way
• 

  Meet Eli Lilly’s New Phase 3 Alzheimer’s Drug, Remternetug
• 

  Why Some Researchers Are Calling Alzheimer’s “Type 3 Diabetes”
• 

  First-Ever Drug for Alzheimer’s Agitation, Brexpiprazole, Nears Finish Line
• 

  CTAD: Lecanemab On Track to File for FDA Approval In Early 2023
• 

  Natural Supplements for Alzheimer’s Disease
• 

  Why Chris Hemsworth Is Worried About Alzheimer’s: Meet the APOE4 Gene
• 

  Alzheimer’s Drugs 101: How Do Cholinesterase Inhibitors Work?
• 

  Pills to Patches: Exploring New Formats for Alzheimer’s Treatments
• 

  Foods to Reverse Dementia? Here’s What the Science Says
• 

  What Parts of the Brain Does Alzheimer’s Affect?
• 

  A Death During an Alzheimer’s Drug Trial Ignites Safety Concerns

Previous222324Next